Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent
1992-07-13
1993-04-06
Cashion, Jr., Merrell C.
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
514826, 514861, A61K 3766
Patent
active
052001776
ABSTRACT:
A method of treating patients having chronic, severe allergic disorders, such as atopic dermatitis or steroid-dependent asthma, with gamma interferon is disclosed. The method involves treating patients afflicated with atopic dermatitis or steroid-dependent asthma with effective dosages of gamma interferon, which reduces the clinical severity of their disease.
REFERENCES:
Goodman and Gillman's: The Pharmacological Basis of Therapeutics, 8th Ed., p. 632, (1990).
McFadden Harrison's Principles of Internal Medicine, 12th Edition, pp. 1047-1053 (1991).
Stedman's Medical Dictionary, 24th Edition p. 443.
H. C. Maguire et al., Int. Arch. Allergy Appl. Immunol., 88:345 347 (1989).
J. M. Parkin et al., Br. Med. Journal, 294:2285-1186 (1987).
M. Boduniewicz et al., J. Allergy Clin. Immunol., 83:196 (1989) (Abstract).
D. Y. M. Leung et al., Clin. Res., 37(2):239A (Apr. 1989) (Abstract).
Geha Raif S.
Leung Donald Y. M.
Cashion Jr. Merrell C.
Koh Choon P.
The Children's Medical Center Corporation
LandOfFree
Treatment of atopic disorders with gamma-interferon does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of atopic disorders with gamma-interferon, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of atopic disorders with gamma-interferon will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-534705